Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (61-70 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|November 1, 1975
Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansionC E Myers, R C Young, B A Chabner
Biochemical Pharmacology|January 1, 1978
Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniquesR G Stoller, C E Myers, B A Chabner
Biochemical Pharmacology|November 1, 1973
Deamination of 5-azacytidine by a human leukemia cell cytidine deaminaseB A Chabner, J C Drake, D G Johns
Bulletin Du Cancer|January 1, 1979
Ara-C metabolism: implications for drug resistance and drug interactionsB A Chabner, K R Hande, J C Drake
Cancer Research|May 1, 1976
Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumorC E Myers, R C Young, B A Chabner
Molecular and Cellular Biochemistry|January 1, 1983
Kinetic behaviour and allosteric regulation of human deoxycytidylate deaminase derived from leukemic cellsP H Ellims, A Y Kao, B A Chabner
Metabolism: Clinical and Experimental|March 1, 1970
Effect on dietary pyridoxine deficiency on experimental porphyriaB A Chabner, J A Stein, D P Tschudy
Cancer Treatment Reports|October 1, 1983
Symposium on cellular resistance to anticancer drugs. IntroductionB A Chabner, N J Clendeninn, G A Curt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1984
Gene amplification in drug resistance: of mice and menG A Curt, K H Cowan, B A Chabner
Cancer Treatment Reports|January 1, 1981
Clinical pharmacology of methotrexateB A Chabner, R C Donehower, R L Schilsky
Pageof 25

Showing results (61-70 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|November 1, 1975
Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansionC E Myers, R C Young, B A Chabner
Biochemical Pharmacology|January 1, 1978
Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniquesR G Stoller, C E Myers, B A Chabner
Biochemical Pharmacology|November 1, 1973
Deamination of 5-azacytidine by a human leukemia cell cytidine deaminaseB A Chabner, J C Drake, D G Johns
Bulletin Du Cancer|January 1, 1979
Ara-C metabolism: implications for drug resistance and drug interactionsB A Chabner, K R Hande, J C Drake
Cancer Research|May 1, 1976
Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumorC E Myers, R C Young, B A Chabner
Molecular and Cellular Biochemistry|January 1, 1983
Kinetic behaviour and allosteric regulation of human deoxycytidylate deaminase derived from leukemic cellsP H Ellims, A Y Kao, B A Chabner
Metabolism: Clinical and Experimental|March 1, 1970
Effect on dietary pyridoxine deficiency on experimental porphyriaB A Chabner, J A Stein, D P Tschudy
Cancer Treatment Reports|October 1, 1983
Symposium on cellular resistance to anticancer drugs. IntroductionB A Chabner, N J Clendeninn, G A Curt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1984
Gene amplification in drug resistance: of mice and menG A Curt, K H Cowan, B A Chabner
Cancer Treatment Reports|January 1, 1981
Clinical pharmacology of methotrexateB A Chabner, R C Donehower, R L Schilsky
Pageof 25